Contact Us
14 January 2013
Posted In

High Through-Put Mechanism of Action Screening

Sibelius has completed a final report on the Mechanism of Action (MOA) of an active anti-ageing compound from a world leading cosmeceutical company.

The ChronoscreenTM has been successfully used for the first time for analysis of the compound's MOA in C. elegans. Using RNAi knockdown and the high through-put, phenotypic screening technology of the ChronoscreenTM, Sibelius has been able to determine pathways involved in the activity of this anti-ageing compound. 

About Sibelius Natural Products
Sibelius is a developer and marketer of high-value, clinically validated natural ingredients for use in dietary supplements, foods and beverages. The company is focused on building modern scientific evidence behind well-known botanicals, helping consumers to make informed decisions about the supplements they choose to purchase. Sibelius’ ingredient portfolio supports unique claims associated with cognition, sleep, anxiety, inflammation, cardiovascular health and men’s health. For more information, please fill in the form below:
Search
Categories
Subscribe to Our Newsletter
Keep up to date with the latest insights
news, events, developments and
product launches
Newsletter Subscribe

How can we help you?

Please fill in the form below and a member of the team will get back to you. To read our privacy policy, click here.
How can we help?
crossmenu